Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 614 (ZNF614) is a member of the zinc finger protein family in humans, characterized by the presence of zinc finger domains that typically facilitate binding to DNA. ZNF614 is predicted to function as a sequence-specific DNA-binding transcription factor, possibly involved in the regulation of gene expression by RNA polymerase II, and is localized to the nucleus. The protein may play a role in transcriptional regulation, as is common among zinc finger proteins, but the specific target genes and regulatory pathways of ZNF614 are not well characterized. There is no strong evidence that it acts as a therapeutic target or is currently drugged, nor is there a significant direct link to major diseases, though its expression has been profiled in various cancer tissues. The principal function is likely in gene regulation and possibly broader aspects of chromatin biology, consistent with functions annotated for zinc finger protein families.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 614 (ZNF614).